Medical Devices Market Research Reports & Consulting

Market Reports

• Orthopedic Braces & Supports Market Size, Growth by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Rigid, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Pharmacies) & Region - Global Forecasts to 2027

  The global orthopedic braces and supports market is projected to reach USD 4.6 billion by 2027, at a CAGR of 5.8% during the forecast period. The vendors operating in the orthopedic braces and supports market include DJO Finance LLC (US), Ossur HF (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and Essity (Sweden) were the top five players in the global orthopedic braces and supports market. Other prominent players operating in this market include 3M (USA), Ottobock Holding GmbH (Germany), Thuasne Group (France), Zimmer Biomet Holdings, Inc. (US), ALCARE (Japan), Bird & Cronin, Inc. (US), Nippon and Sigmax (Japan), and Becker Orthopedic (US), among others.

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Cancer Biomarkers Market by Type (Protein, Genetic), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnostics, R&D, Prognostics), Region - Global Forecast to 2026

  The global cancer biomarkers market boasts a total value of $12.4 billion in 2021 and is projected to register a growth rate of 17.7% to reach a value of $28.2 billion by 2026. The major players F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US), Becton, Dickinson and Company (US), Merck Millipore (US), Agilent Technologies (US), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Hologic, Inc. (US), Quest Diagnostics (US), Centogene N.V. (Germany), PerkinElmer, Inc. (US), Siemens Healthineers (Germany), Exact Sciences (US), R&D Systems, Inc. (US), BioVision, Inc. (US), Olink (Sweden), Asuragen, Inc. (US), Meso Scale Diagnostics, LLC (US), Invivoscribe, Inc. (US), Seegene Technologies, Inc. (South Korea).

  • Published: March 2022
  • Price: $ 7150
  • TOC Available:

• Medical Radiation Detection, Monitoring & Safety Market by Detector (Gas-Filled, Scintillators, Solid-State), Product (Personal Dosimeters, Passive Dosimeters) Safety (Full-Body Protection) & End User (Hospitals, Non-Hospitals) - Global Forecast to 2027

  The global Medical Radiation Detection, Monitoring, & Safety Market is projected to reach USD 1.4 billion by 2027, at a CAGR of 6.8% during the forecast period. The major players operating in this market are Fortive (US), Mirion Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Ludlum Measurements, Inc. (US), IBA Worldwide (Belgium), AliMed, Inc. (US), Polimaster Ltd. (Republic of Belarus), AmRay Group (Ireland), Infab, LLC (US), Burlington Medical (US), Bertin Instruments (France), Radiation Detection Company (RDC) Inc. (US), Arrow-Tech, Inc. (US), Centronic (UK), SE International, Inc. (US), ATOMTEX (Belarus), Nucleonix Systems (India), Alpha Spectra, Inc. (US), LND (US), Bar•Ray Products (US), Trivitron Healthcare (India), Micron Technology, Inc. (UK), Scionix Holland (Netherland), Lite Tech Industries, LLC (US), BLOXR Solutions, LLC (US).

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Endoscopic Retrograde Cholangiopancreatography Market/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecasts to 2026

  The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026, at a compound annual growth rate (CAGR) of 9.6% during the forecast period. The major players Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Breast Reconstruction Market Size, Growth by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecasts to 2026

  The global breast reconstruction market size is projected to reach USD 647 million by 2026, at a CAGR of 2.7%. The prominent players in this market are Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil).

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Dental 3D Printing Market by Product(Material (Plastic, Metal), Equipment(3D Scanner & Printer), Service), Technology (Vat Photopolymerization, FDM, SLS, Polyjet), Application(Prosthodontics, Implants), End-User(Labs, Hospitals) - Global Forecast to 2027

  The global dental 3D printing market in terms of revenue was estimated to be worth $3.2 billion in 2022 and is poised to reach $7.9 billion by 2027, growing at a CAGR of 20.2% from 2022 to 2027. Market growth is driven by factors such as the increasing incidence of dental caries and other dental diseases, rising demand for cosmetic dentistry, the growing adoption of dental 3D printers in dental hospitals and clinics, and the increasing growth of the geriatric population. On the other hand, the rising number of large dental practices is expected to limit market growth to a certain extent.

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2027

  The global electrophysiology market size is projected to reach USD 11.6 billion by 2027, at a CAGR of 9.4%. The prominent players in this market includes Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), and Acutus Medical, Inc. (US).

  • Published: March 2022
  • Price: $ 4950
  • TOC Available:

• Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) & Region - Global Forecasts to 2026

  The global organ preservation market in terms of revenue was estimated to be worth $230 million in 2021 and is poised to reach $317 million by 2026, growing at a CAGR of 6.6% from 2021 to 2026. The prominent players in this market includes Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Capnography Equipment Market by Product (Multiparameter & Standalone Capnometer, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Trauma, Emergency Care), End User (Hospital) - Global Forecasts to 2027

  The global capnography equipment market size is projected to reach USD 436 million by 2027, at a CAGR of 4.6% during the forecast period. The leading players in this market are Becton, Dickinson, and Company (US), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (General Electric Company), Koninklijke Philips N.V. (Netherlands), and Medtronic plc (Ireland).ZOLL Medical Corporation (Asahi Kasei) (Japan), Masimo Corporation (US), and Nihon Kohden (Japan).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Needle-Free Injection System Market by Technology (Jet, Spring, Micro-array Patch), by Product (Prefilled, Fillable), Type of Medication (Liquid, Powder), Application (Vaccination, Dermatology), End Users (Hospital, Homecare) - Global Forecast to 2026

  The needle-free injection system market is expected to grow from USD 124 million in 2021 to USD 272 million by 2026, at a compound annual growth rate (CAGR) of 17.0% during the forecast period.The prominent players PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), and Bioject Medical Technologies (US).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Molecular Quality Controls Market by Product (Independent, Instrument Specific (PCR, DNA Sequencing)), Application (Infectious Diseases Diagnostic), Analyte Type, End User (Hospitals, Diagnostic Lab) – Global Forecasts to 2026

  The global molecular quality controls market size is projected to reach USD 226 million by 2026, at a CAGR of 6.7% during the forecast period. The prominent players in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Ortho-Clinical Diagnostics, Inc. (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics, Inc. (US), Microbix Biosystems Inc. (Canada), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Gastrointestinal Stent Market with COVID-19 Impact by Product (biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents), Material (self-expanding metal stents and plastic stents), Application, End User - Forecast to 2026

  The gastrointestinal stent market is expected to grow from USD 457 million in 2021 to USD 600 million by 2026, at a CAGR of 5.6% during the forecast period. Some of the prominent players in this market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea), Micro-Tech(Nanjing) Co., Ltd. (China), Endo-Flex GmbH (Germany), MI-Tech (South Korea), Hobbs Medical Inc. (US), QualiMed (Germany), UK Medical (UK), CITEC (China), Medorah Meditek Pvt. Ltd. (India), BCM Corporation (South Korea), and Leufen Medical GmbH (Germany).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End user (Hospital, ASC, Academia) - Global Forecasts to 2027

  The aspiration and biopsy needles market is expected to grow from USD 879 million in 2021 to USD 1,303 million by 2027, at a compound annual growth rate (CAGR) of 6.8% during the forecast period.The Leading Players CONMED Corporation (US), Medtronic Plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), Ranfac Corporation (US), HAKKO CO., LTD (Japan), and Merit Medical Systems (US)

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026

  The global companion diagnostics market in terms of revenue was estimated to be worth $5.5 billion in 2021 and is poised to reach $9.9 billion by 2026, growing at a CAGR of 12.6% from 2021 to 2026. The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Qiagen N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Abnova Corporation (Taiwan), Guardant Health, Inc. (US), ICON Plc (Ireland), BioGenex Laboratories, Inc. (US), Invivoscribe Technologies (US), ArcherDX, Inc. (US), NG Biotech (France), Q² Solutions (US), Amoy Diagnostics Co., Ltd. (China), Abacus Diagnostica Oy (Finland), Asuragen Inc. (US), SAGA Diagnostics (Sweden), Meso Scale Diagnostics, LLC. (US), and Creative Biolabs (US).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026

  The global point of care molecular diagnostics market in terms of revenue was estimated to be worth $2.8 billion in 2021 and is poised to reach $4.1 billion by 2026, growing at a CAGR of 8.2% from 2021 to 2026. The major players Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Danaher Corporation (US), Quidel Corporation (US), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. (US), Biocartis NV (Belgium), Meridian Bioscience, Inc. (US), Thermo Fisher Scientific, Inc. (US), Lucira Health, Inc. (US), Cue Health (US), OpGen, Inc. (US), Binx Health, Inc. (US), Molbio Diagnostics Pct. Ltd. (India), Genomadix (Canada), Visby Medical, Inc. (US), QuikPath PTE Ltd. (Singapore), MD-Bio (US), QuantuMDx Group Ltd. (UK), Aidian Oy (Finland), and GeneSTAT Molecular Diagnostics, LLC (US).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities) - Global Forecast to 2026

  The global Veterinary Infectious Disease Diagnostics Market boasts a total value of $1.7 billion in 2021 and is projected to register a growth rate of 9.0% to reach a value of $2.6 billion by 2026. The major players operating in this market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMérieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US).

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay, Instruments, Software), Test Type (Lab, POC), Pathogen (Bacterial, Viral, Fungal), End User (Hospital, Pathology Lab) & Region - Global Forecast to 2026

  The global sepsis diagnostics market in terms of revenue was estimated to be worth $503 million in 2021 and is poised to reach $771 million by 2026, growing at a CAGR of 8.9% from 2021 to 2026. Some of the prominent players in this market are bioMérieux (France), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other players include T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), among others.

  • Published: February 2022
  • Price: $ 4950
  • TOC Available:

• Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostic, Therapeutic), End User (Hospitals, Blood Banks) (2022 - 2027)

  The global blood collection devices market is projected to reach USD 8.42 billion by 2027, at a CAGR of 6.8% during forecasted period. Some of the key players include Becton, Dickinson and Company (US), Terumo BCT (US), Fresenius Kabi AG (Germany), Grifols S.A.(Spain), Haematonics (US), Nipro Medical Corporation (Japan), Greiner Holding (Austria), Quest Diagnostics (US), SARSTEDT AG & Co. (Germany), Macopharma (France), Smiths Medical (US), Cardinal Health (US), and Retractable Technologies (US)

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display (Color, B&W), Portability (Trolley, POC), Application (Gynecology, Cardiology, Orthopedic), Component (Probe), End user (Hospitals) - Global Forecasts to 2026

  The global ultrasound market boasts a total value of $6.7 billion in 2021 and is projected to register a growth rate of 6.3% to reach a value of $9.0 billion by 2026. The major players GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), Siemens Healthineers AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Korea), Mindray Medical International Limited (China), Analogic Corporation (US), Esaote S.p.A (Italy), Carestream Health (US), CURA Healthcare (India), Chison Medical Technologies Co., Ltd. (China), Mobisante, Inc. (US), Neusoft Corporation (China), Clarius Mobile Health (Canada), Medgyn Products, Inc. (US), and United Imaging Healthcare Co., Ltd. (China)

  • Published: January 2022
  • Price: $ 7150
  • TOC Available:

• Surface Disinfectant Market by Composition (Alcohols, Chlorine, Quaternary Ammonium), Type (Liquid, Wipes, Sprays), Application (Surface, Instrument), End User (Hospital, Diagnostic and Research Laboratories) & Region - Global Forecast to 2026

  The global surface disinfectant market in terms of revenue was estimated to be worth $2.9 billion in 2021 and is poised to reach $4.3 billion by 2026, growing at a CAGR of 8.4% from 2021 to 2026. Growth of this market is driven by the rising number of stringent regulations for the use of surface disinfectants and the increasing use of newer surface disinfectants for sanitization. However, a rise in demand for cleaning products, sanitizers, and disinfectants is expected to have a positive impact on market growth.

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Stoma Care Market / Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region - Global Forecast to 2026

  The stoma/ostomy care market is expected to grow from USD 2.6 billion in 2021 to USD 3.2 billion by 2026, at a CAGR of 4.3% during the forecast period. The stoma/ostomy care market is dominated by Coloplast Corp (Denmark), Hollister Incorporated (US), B. Braun Melsungen AG (Germany), ConvaTec Inc. (England), Salts Healthcare (UK), Welland Medical Limited (UK), and Flexicare Group Limited (UK).

  • Published: January 2022
  • Price: $ 6780
  • TOC Available:

• Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL,RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy,Lumpectomy), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecasts to 2026

  The Breast Lesion Localization Market is projected to reach USD 305 million by 2026, at a CAGR of 4.6% during the forecast period. Key players in the breast lesion localization market Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US), Laurane Medical LLC (France), Endomagnetics Ltd. (UK), Intramedical Imaging, LLC (US), Isoaid (US), Surgiceye GmbH (Germany), Ranfac Corp. (US), Mermaid Medical Group (Denmark), Izi Medical Products, LLC (US), MatekMedikal (Turkey), Tsunami Medical Srl (Italy), BPB Medica (Italy), Sirius Medical Systems B.V. (Netherlands), Molli Surgical Inc. (Canada). Other players in the breast lesion localization market are Sterylab S.R.L. (Italy), CP Medical (Georgia), MDL SRL (Italy), Biomedical Srl (Italy), Elucent Medical (US), Vigeosrl (Italy), and Medax Medical Devices (Italy).

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Surgical Instrument Tracking System Market by Technology (RFID, Barcode), Component(Hardware (Scanner, Reader, Tags), Software, Services), End User(Hospital (Public, Private)), Region - Global Forecast to 2026

  The surgical instrument tracking systems market is projected to reach USD 406 million by 2026, at a compound annual growth rate (CAGR) of 14.9% during the forecast period. Prominent players in the market are Fortive Corporation (US), Material Management Microsystems (US), Becton, Dickinson and Company (BD) (US), Haldor Advanced Technologies (US), Getinge AB (Sweden), STERIS (US), STANLEY Healthcare (US), Mobile Aspects (US), Integra LifeSciences Holdings Corporation (US), Xerafy (Singapore), B. Braun Melsungen AG (Germany), SpaTrack Medical Limited (UK), Scanlan International, Inc. (US), Case Medical (US), ASANUS Medizintechnik GmbH (Germany), Keir Surgical Ltd. (Canada), TechnoSource Australia Pty Ltd. (Australia), NuTrace (US), Vizinex RFID (US), ScanCARE Pty Ltd. (US), RFID Discovery (UK), Healthtech Pivot LLP (India), RMS Omega Healthcare (US), Avery Dennison Corporation (US), and Surgical Safety Scanner (US).

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• North American Radiation Protection Apron Market by Type (Front Protection, Vest & Skirt, Full Wrap, Pregnancy Lead Apron), Material (Lead Apron, Light Lead Composite Apron, Lead Free Apron), Country (US, Canada) - Forecast to 2026

  The north american radiation protection apron market is expected to grow from 35 million in 2021 to USD 48 million by 2026, at a CAGR of 6.9% during the forecast period. The major players operating in the North American radiation protection aprons market include Infab Corporation (US), Bar-Ray Products (US), AliMed, Inc. (US), Burlington Medical (US), Shielding International, Inc. (US), Protech Medical (US), AADCO Medical, Inc. (US), Lite Tech (US), Barrier Technologies (US), and BLOXR Solutions (US).

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2026

  The global drug screening market is expected to grow from USD 5.3 billion in 2021 to USD 11.6 billion by 2026, at a compound annual growth rate (CAGR) of 16.8% during the forecast period. The prominent players Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan).

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Multiplex Assays Market by Product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence, Application (R&D, Diagnosis), End User (Pharma & Biotech, Hospital) & Region - Global Forecasts to 2026

  The multiplex assays market is projected to reach USD 4.3 billion by 2026, at a CAGR of 7.6% during the forecast period. The prominent players operating in this market include Illumina, Inc. (US), Luminex Corporation (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), and Becton, Dickinson and Company (US).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product (Readers, Kits) Technique, End User - Global Forecast to 2026

  The lateral flow assays market is projected to reach USD 12.6 billion by 2026, at a CAGR of 2.0% during the forecast period. The prominent players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), and Merck KGaA (Germany).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Cold Plasma Market Size, Growth by Industry (Textile, Electronics & Semiconductors, Polymers & Plastic, Food & Agriculture, Medical, Others), Application (Adhesion, Printing, Wound Healing), Regime (Atmospheric, Low Pressure) - Global Forecasts to 2026

  The global cold plasma market in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 15.0% from 2021 to 2026. The prominent players in this market are Apyx Medical Corporation (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i (UK), Relyon Plasma GmbH, (Germany), Henniker Plasma (UK), Enercon Industries (US), AcXys Plasma Technologies (France), Plasmatreat (Germany), Tantec A/S (Denmark), Europlasma (Belgium), Thierry Corporation (Germany), Surfx Technologies (US), SOFTAL Corona & Plasma (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), terraplasma GmbH (Germany), Molecular Plasma Group (Germany), and CINOGY GmbH (Germany), US Medical Innovation (US).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Veterinary Imaging Market by Product (Ultrasound (2D, 3D, Doppler), X-Ray (CR, DR), MRI, CT, Software, Reagent), Therapeutic Area (Orthopedics, Gynecology, Oncology, Dentistry), Animal (Small, Large), End User (Hospital, Clinic) & Region - Global Forecasts to 2026

  The global Veterinary Imaging Market in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $2.3 billion by 2026, growing at a CAGR of 7.0% from 2021 to 2026. The prominent players GE Healthcare (US), Agfa-Gevaert N.V. (Belgium), Carestream Health (US), Esaote S.p.A (Italy), IDEXX Laboratories, Inc. (US), Mindray Medical International Limited (China), Canon Inc. (Japan), Heska Corporation (US), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Konica Minolta Inc. (Japan), Samsung Electronics Co., Ltd. (South Korea), E.I. Medical Imaging (US), IMV imaging (UK), SEDECAL (Spain). Other players in the veterinary imaging market are Clarius Mobile Health (Canada), Shenzhen Ricso Technology Co. Ltd. (China), Epica Animal Health (US), and ClearVet Digital Radiography Systems (US), MinXray Inc. (US), Hallmarq Veterinary Imaging (UK), Shantou Institute of Ultrasonic Instruments Co., Ltd (China), Sonoscape Medical Corp. (China), and Reproscan (US).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Patient Handling Equipment Market by Type (Patient Transfer Devices (Lifts, Slings, Sliding Sheets), Electrical Medical Beds, Mobility Devices (Powered Wheelchairs, Mobility Scooters) Stretcher, End User (Hospitals, Home Care) - Global Forecast to 2026

  The patient handling equipment market is expected to grow from USD 12.4 billion in 2021 to USD 13.9 billion by 2026, at a CAGR of 2.3% during the forecast period. The key players operating in the patient handling equipment market include Hill-Rom Holdings (US), Arjo (Sweden), Invacare Corporation (US), and Stryker (US).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) - Global Forecast to 2026

  The global peripheral vascular devices market is expected to grow from USD 10.3 billion in 2021 to USD 13.4 billion by 2026, at a compound annual growth rate (CAGR) of 5.3% during the forecast period.The major players Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Wearable Healthcare Devices Market by Product(Trackers, Smartwatch), Type(Diagnostic(BP, Glucose, ECG), Therapeutic(Pain, Insulin)), Grade(Consumer, Clinical), Channel(Pharmacies, E-commerce), Application(Fitness, RPM), & Region - Global Forecasts to 2026

  The global wearable healthcare devices market is expected to grow USD 30.1 billion by 2026, at a compound annual growth rate (CAGR) of 13.2% during the forecast period.The major players Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), GE Healthcare (US), Fitbit Inc. (US), Abbott Laboratories (US), OMRON Corporation (Japan), Garmin Ltd. (US), Dexcom Inc. (US), Masimo Corporation (US), Medtronic PLC (Ireland), BioTelemetry Inc. (US), Preventice Solutions Inc. (US), iRhythm Technologies Inc. (US), Contec Medical Systems Co. Ltd. (China), MediBioSense Ltd. (UK), VitalConnect (US), Cyrcadia Health Inc. (US), Ten3T Healthcare (India), Verily Life Sciences (US), MinttiHealth (China), Bio-Beat (Israel), Biotricity Inc. (US), iHealth Lab Inc. (US), Vivalink (US), Gentag (US).

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Blood Screening Market by Technology (Nucleic Acid Amplification, (Real-Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software), End User (Blood Bank, Hospital) & Region - Global Forecast to 2026

  The global blood screening market in terms of revenue was estimated to be worth $2.5 billion in 2021 and is poised to reach $3.8 billion by 2026, growing at a CAGR of 8.4% from 2021 to 2026. The major players of this industry are Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), Beckman Coulter, Inc. (Danaher) (US), DiaSorin (Italy), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), Ortho Clinical Diagnostics Inc. (US), GE Healthcare (US), Merck KGaA (Germany), PerkinElmer (US), Bio-Techne Corporation (US), GFE (Germany), Trinity Biotech (Ireland), Mindray (China), Maccura Biotechnology Co., Ltd. (China), Immucor, Inc. (US), Cellabs (Australia), Abnova Corporation (Taiwan), Enzo Biochem, Inc. (US), and Cepheid (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026

  The global ECMO Machine Market in terms of revenue was estimated to be worth $531 million in 2021 and is poised to reach $673 million by 2026, growing at a CAGR of 4.9% from 2021 to 2026. The key players operating in this market are Getinge Group (Sweden), Medtronic plc (US), Fresenius Medicalcare AG & Co. KGAA (Germany), Microport (China), and Terumo Cardiovascular Systems Corporation (Japan). The other leading market players include Livanova plc (UK), Nipro Corporation (Japan), Eurosets S.R.L. (Italy), Origin Biomedical (US), Cytosorbents Corporation (Australia), and Abiomed (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026

  The global hepatitis testing market is projected to reach USD 3.6 billion by 2026, at a CAGR of 4.7% during the forecast period. The global hepatitis testing market is consolidated. The prominent players operating in this market include include F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), bioMérieux SA (France), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (US), MedMira Inc. (Canada), Fujirebio US, Inc. (Japan), Grifols, S.A. (Spain), Orasure Technologies (US), GenMark Diagnostics Inc. (US), Vela Diagnostics (Singapore), and Epitope Diagnostics (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026

  The global defibrillator market in terms of revenue was estimated to be worth $11.4 billion in 2021 and is poised to reach $18.2 billion by 2026, growing at a CAGR of 9.7% from 2021 to 2026. The prominent key players in this market are Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan) and MicroPort (China).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• In Vitro Fertilization Market Size, Growth by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2026

  The global In Vitro Fertilization Market boasts a total value of $638 million in 2021 and is projected to register a growth rate of 9.1% to reach a value of $987 million by 2026. Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Oral Care Market by Product (Toothbrush (Manual, Electric, Battery), Toothpaste (Pastes, Gels, Powder, Polish), Breath Freshener, Rinse) & Distribution Channel (Consumer Stores, Retail Pharmacy, e-Commerce), & Region - Global Forecast to 2026

  The global oral care market in terms of revenue was estimated to be worth $47.2 billion in 2021 and is poised to reach $54.9 billion by 2026, growing at a CAGR of 3.1% from 2021 to 2026. Asia-Pacific dominated the oral care market, followed by Europe and North America. The large share of Asia Pacific can be attributed to growing dental tourism, the increasing focus of prominent players on emerging Asian countries, and increasing healthcare expenditure in the region.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• ASEAN and North Asian Point of Care/Rapid Diagnostics Market by Product (Glucose Monitoring, COVID, HIV, STDs, HAIs, Influenza, Tropical & Respiratory diseases), Technique (Rapid test, Molecular diagnostics), User (Hospital, Home Care) - Forecast to 2026

  The ASEAN and North Asian Point of Care/Rapid Diagnostics market is expected to grow from USD 2.0 billion in 2021 to USD 3.9 billion by 2026, at a compound annual growth rate (CAGR) of 13.0% during the forecast period.The major players Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Abbott Laboratories (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sysmex (Japan), Cardinal Health (US), Quidel (US), GE Healthcare (US) EKF Diagnostics (UK), bioMérieux SA (France), Accubiotech (China), PTS Diagnostics (US), Chembio Diagnostics (US) Trinity Biotech (Ireland), Johnson and Johnson(US), Sekisui Diagnostics (US), Nova Biomedical (US), Thermo Fisher Scientific (US), Ortho Clinical Diagnostics (US) and Bio-Techne (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes), Application (Cancer, Diabetes), Facility of Use (Hospitals) - Global Forecasts to 2026

  The global pharmaceutical drug delivery market in terms of revenue was estimated to be worth $1,656.9 billion in 2021 and is poised to reach $2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026. Major players in this market includes Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), Antares Pharma, Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), 3M (US), Merck & Co., Inc. (US), Sanofi (France), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca plc. (UK), Eli Lilly and Company (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol-Myers Squibb (US), Gerresheimer AG (Germany), Boston Scientific Corporation (US), Nimbus Therapeutics (US), Kite Pharma (US), and IDEAYA Biosciences, Inc. (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper and Full Body) & Mobility (Mobile, Stationary) - Global Forecasts to 2026

  The global medical exoskeleton market boasts a total value of $0.2 billion in 2021 and is projected to register a growth rate of 45.0% to reach a value of $1.0 billion by 2026. Some of the leading players in the Medical exoskeleton market include Key players in this market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd. (Israel), Parker Hannifin Corp (US), CYBERDYNE Inc. (Japan), Bionik Laboratories Corp (Canada), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (a subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet (Luxembourg).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Pain Management Devices Market by Type (Neurostimulator, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026

  The global pain management devices market in terms of revenue was estimated to be worth $2.2 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 8.6% from 2021 to 2026. Growth of this market is driven by an expanding patient population, growing demand for long-term pain management among the geriatric population, and increasing preference for pain management devices owing to the adverse effects of pain medications on patients. However, product recalls and high procedural costs are likely to challenge market growth in the coming years.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Injection Pen Market Size, Growth by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care), and Region - Global Forecasts to 2026

  The global injection pen market size is projected to reach USD 53.3 billion by 2026, at a CAGR of 7.2%. The prominent players in this market are Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (US), Novartis AG (Switzerland), Gerresheimer AG (Germany), Bespak Europe Ltd. (UK), SHL Medical AG (Switzerland), Boehringer Ingelhem (Germany), Nemera France SA, Companion Medical (US), and Jiangsu Delfu Medical Devices Co., Ltd. (China).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Hyperspectral Imaging System Market by Product (Camera, Accessories), Technology (Snapshot, Push broom), Application (Military, Remote Sensing (Agriculture, Mining, Environmental), Machine Vision, Life Sciences & Diagnostic) - Global Forecast to 2027

  The global hyperspectral imaging systems market is expected to grow from USD 18.1 billion in 2022 to USD 42.3 billion by 2027, at a compound annual growth rate (CAGR) of 18.5% during the forecast period. The prominent players operating in this market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), BaySpec, Inc. (US), Cubert GmbH (Germany), Inno-Spec GmbH (Germany), XIMEA GmbH (Germany), Imec (Belgium), and ChemImage Corporation (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecasts to 2026

  The global Anatomic Pathology Market in terms of revenue was estimated to be worth $35.1 billion in 2021 and is poised to reach $49.1 billion by 2026, growing at a CAGR of 7.0% from 2021 to 2026. The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Brain Monitoring Market by Product (Accessories, MRI, CT, PET, EEG, EMG, MEG, ICP, Electrode, Paste, Gel, Battery, Cable, Invasive), Disease (TBI, Stroke, Dementia, Epilepsy, Headache, Sleep), End User (Hospital, Clinic, ASC) & Region - Global Forecasts to 2026

  The global Brain Monitoring Market in terms of revenue was estimated to be worth $5.8 billion in 2021 and is poised to reach $8.0 billion by 2026, growing at a CAGR of 6.5% from 2021 to 2026. Some of the leading players in the Brain Monitoring market include Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), Edwards Lifesciences Corporation (US), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Masimo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Neurosoft (Russia), CGX (a Cognionics Company) (US), Emotive (US), InfraScan, Inc. (US), Neusoft Medical Systems Co., Ltd. (China), Clinical Science Systems (Netherlands), Noraxon (US), SternMed GmbH (Germany), and Rimed (US).

  • Published: October 2021
  • Price: $ 4950
  • TOC Available:

• Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care) - Global Forecast to 2026

  The respiratory care devices market is expected to grow from USD 18.4 billion in 2021 to USD 27.6 billion by 2026, at a compound annual growth rate (CAGR) of 8.5% during the forecast period.Some of the prominent players operating in this market include Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc. (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare (New Zealand), Drager AG (Germany), Invacare Corporation (US), Nihon Kohden (Japan), Getinge AB (Sweden) and Air Liquide (France).

  • Published: October 2021
  • Price: $ 4950
  • TOC Available:

• Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) - Global Forecasts to 2026

  The global vascular closure devices market is projected to reach USD 1.3 billion by 2026, at a CAGR of 7.0% during the forecast period. The prominent players operating in this market include Terumo Corporation (Japan), Abbott (US), Cardinal Health (US), Cardiva Medical, Inc. (US), and Medtronic Plc. (Ireland).

  • Published: October 2021
  • Price: $ 4950
  • TOC Available:

• Infertility Treatment Market Size, Growth by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) & Region - Global Forecasts to 2026

  The global infertility treatment market boasts a total value of $1.5 billion in 2021 and is projected to register a growth rate of 8.1% to reach a value of $2.2 billion by 2026. The Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US),

  • Published: October 2021
  • Price: $ 4950
  • TOC Available:

• Digital X-ray Market by Portability (Fixed, Portable), Applications (General, Dental, Mammography, Cancer, Fluoroscopy), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region - Global Forecast to 2026

  The global digital X-ray market is expected to reach USD 16.4 billion by 2026, at a CAGR of 8.1% during the forecast period. The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan).

  • Published: October 2021
  • Price: $ 4950
  • TOC Available:

• First
• Previous
• 3
• 4
• 5
• 6
• 7
• Next
• Last